期刊
NATURE COMMUNICATIONS
卷 9, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41467-018-05420-0
关键词
-
资金
- German ministry of education and research (BMBF, Bonn, Germany) [01GM1511C, 01GM1511F, 01GM1511D]
- DFG [SFB/TRR83, SE 1944/1-1, SPP1757]
- German Ministry of Education and Research (BMBF, CMT-BIO) [FKZ: 01ES0812]
- German Ministry of Education and Research (BMBF, CMT-NET) [FKZ: 01GM1511C]
- German Ministry of Education and Research (BMBF, CMT-NRG, ERA-NET'ERARE3') [FKZ: 01GM1605]
- Association Francaise contre Les Myopathies (AFM) [15037]
- European Leukodystrophie Society [ELA 2014-020I1]
- DFG (CNMPB)
- ERC
In patients with Charcot-Marie-Tooth disease 1A (CMT1A), peripheral nerves display aberrant myelination during postnatal development, followed by slowly progressive demyelination and axonal loss during adult life. Here, we show that myelinating Schwann cells in a rat model of CMT1A exhibit a developmental defect that includes reduced transcription of genes required for myelin lipid biosynthesis. Consequently, lipid incorporation into myelin is reduced, leading to an overall distorted stoichiometry of myelin proteins and lipids with ultrastructural changes of the myelin sheath. Substitution of phosphatidylcholine and phosphatidylethanolamine in the diet is sufficient to overcome the myelination deficit of affected Schwann cells in vivo. This treatment rescues the number of myelinated axons in the peripheral nerves of the CMT rats and leads to a marked amelioration of neuropathic symptoms. We propose that lipid supplementation is an easily translatable potential therapeutic approach in CMT1A and possibly other dysmyelinating neuropathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据